153 related articles for article (PubMed ID: 25200921)
21. First-trimester or second-trimester screening, or both, for Down's syndrome.
Malone FD; Canick JA; Ball RH; Nyberg DA; Comstock CH; Bukowski R; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Dukes K; Bianchi DW; Rudnicka AR; Hackshaw AK; Lambert-Messerlian G; Wald NJ; D'Alton ME;
N Engl J Med; 2005 Nov; 353(19):2001-11. PubMed ID: 16282175
[TBL] [Abstract][Full Text] [Related]
22. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
Christiansen M; Nørgaard-Pedersen B
Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
[TBL] [Abstract][Full Text] [Related]
23. Maternal serum free-beta-chorionic gonadotrophin, pregnancy-associated plasma protein-A and fetal nuchal translucency thickness at 10-13(+6) weeks in relation to co-variables in pregnant Saudi women.
Ardawi MS; Nasrat HA; Rouzi AA; Qari MH; Al-Qahtani MH; Abuzenadah AM
Prenat Diagn; 2007 Apr; 27(4):303-11. PubMed ID: 17269128
[TBL] [Abstract][Full Text] [Related]
24. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
[TBL] [Abstract][Full Text] [Related]
25. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
Palomaki GE; Wright DE; Summers AM; Neveux LM; Meier C; O'donnell A; Huang T; Knight GJ; Haddow JE
Prenat Diagn; 2006 Aug; 26(8):730-9. PubMed ID: 16810709
[TBL] [Abstract][Full Text] [Related]
26. Early β-human chorionic gonadotropin trends in vanishing twin pregnancies.
Brady PC; Correia KF; Missmer SA; Hornstein MD; Barton SE
Fertil Steril; 2013 Jul; 100(1):116-21. PubMed ID: 23541408
[TBL] [Abstract][Full Text] [Related]
27. ADAM 12 as a second-trimester maternal serum marker in screening for Down syndrome.
Christiansen M; Spencer K; Laigaard J; Cowans NJ; Larsen SO; Wewer UM
Prenat Diagn; 2007 Jul; 27(7):611-5. PubMed ID: 17465398
[TBL] [Abstract][Full Text] [Related]
28. ADAM12 is an effective marker in the second trimester of pregnancy for prenatal screening of Down syndrome.
Wang M; Lu S; Zhu Y; Li H
Prenat Diagn; 2010 Jun; 30(6):561-4. PubMed ID: 20509157
[TBL] [Abstract][Full Text] [Related]
29. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies.
Benn PA
Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476
[TBL] [Abstract][Full Text] [Related]
30. First trimester prenatal screening among women pregnant after IVF/ICSI.
Gjerris AC; Tabor A; Loft A; Christiansen M; Pinborg A
Hum Reprod Update; 2012 Jul; 18(4):350-9. PubMed ID: 22523111
[TBL] [Abstract][Full Text] [Related]
31. First and second trimester maternal serum inhibin A levels in twins with pre-eclampsia.
Svirsky R; Maymon R; Melcer Y; Klog E; Cuckle H
Prenat Diagn; 2016 Nov; 36(11):1071-1074. PubMed ID: 27731952
[TBL] [Abstract][Full Text] [Related]
32. First trimester maternal serum placental growth factor levels in twin pregnancies.
Cowans NJ; Spencer K
Prenat Diagn; 2013 Dec; 33(13):1260-3. PubMed ID: 24114956
[TBL] [Abstract][Full Text] [Related]
33. The effects of isolated single umbilical artery on first and second trimester aneuploidy screening test parameters.
Tulek F; Kahraman A; Taskin S; Ozkavukcu E; Soylemez F
J Matern Fetal Neonatal Med; 2015 Apr; 28(6):690-4. PubMed ID: 24866346
[TBL] [Abstract][Full Text] [Related]
34. Does a "vanishing twin" affect first-trimester biochemistry in Down syndrome risk assessment?
Chasen ST; Perni SC; Predanic M; Kalish RB; Chervenak FA
Am J Obstet Gynecol; 2006 Jul; 195(1):236-9. PubMed ID: 16626615
[TBL] [Abstract][Full Text] [Related]
35. A comparison between maternal serum free beta-human chorionic gonadotrophin and pregnancy-associated plasma protein A levels in first-trimester twin and singleton pregnancies.
Mashiach R; Orr-Urtreger A; Yaron Y
Fetal Diagn Ther; 2004; 19(2):174-7. PubMed ID: 14764965
[TBL] [Abstract][Full Text] [Related]
36. Impact of inherited thrombophilias on first and second trimester maternal serum markers for aneuploidy.
Derbent AU; Yanik FF; Inegöl Gümüş I; Simavli S; Turhan NÖ
J Matern Fetal Neonatal Med; 2012 Nov; 25(11):2177-81. PubMed ID: 22506595
[TBL] [Abstract][Full Text] [Related]
37. Detection of maternal serum hCG glycoform variants in the second trimester of pregnancies affected by Down syndrome using a lectin immunoassay.
Talbot JA; Spencer K; Abushoufa RA
Prenat Diagn; 2003 Jan; 23(1):1-5. PubMed ID: 12533803
[TBL] [Abstract][Full Text] [Related]
38. First trimester Down syndrome screening: distribution of markers and comparison of assays for quantification of pregnancy-associated plasma protein-A.
Wøjdemann KR; Larsen SO; Rode L; Shalmi A; Sundberg K; Christiansen M; Tabor A
Scand J Clin Lab Invest; 2006; 66(2):101-11. PubMed ID: 16537243
[TBL] [Abstract][Full Text] [Related]
39. First and second-trimester biochemical markers of chromosomal anomalies and their relationship to maternal haemoglobin levels.
Cowans NJ; Spencer K
Prenat Diagn; 2005 Aug; 25(8):693-9. PubMed ID: 16050001
[TBL] [Abstract][Full Text] [Related]
40. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
